CN1255329A - Skin beautifying and whitening composition - Google Patents
Skin beautifying and whitening composition Download PDFInfo
- Publication number
- CN1255329A CN1255329A CN 99124005 CN99124005A CN1255329A CN 1255329 A CN1255329 A CN 1255329A CN 99124005 CN99124005 CN 99124005 CN 99124005 A CN99124005 A CN 99124005A CN 1255329 A CN1255329 A CN 1255329A
- Authority
- CN
- China
- Prior art keywords
- extract
- derivant
- compositions
- endothelin antagonist
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
Abstract
A composition for beautifying and whitening skin contains tyrosinase inhibitor, sun-shielding agent, endothelin agonist, antiphlogistic agent, cutin-scraping agent and antioxidizing agent. Its advantages are high effect, safety and stability. It can be used for cosmetics or external-applied medicine for dermatopathy.
Description
The invention belongs to the household chemicals technical field, relate in particular to a kind of compositions skin Pear Power function.
Along with making rapid progress of science and technology, the development of current cosmetic field and external preparation for skin medicament progressively trends towards bioid and functionalization.How to make cosmetics have the important topic that higher usefulness is the beauty treatment scientific domain.The east women always advocates the whitening effect of " skin coagulates as fat as snow ".The trend of the back to nature that start in the worldwide end of this century makes people be out of conceit with the calmness that hides facial pigmentation with thick foundation cream, therefore press for a kind of preparation that can effectively suppress melanin generation in the body, thereby the skin that reaches truly is bright and clean.In recent years, the market share of whitening and speckle dispelling class cosmetics and external preparation for skin medicament is in growth trend all the time.
At present, the product for the treatment of this class skin of face illness is a lot, for example: Chinese patent: application number 90108630 disclosed " QUBAN SHUANG "; Application number 93104271.2 disclosed a kind of facial membrane made from natural plant and preparation method thereof; Application number 94116788 disclosed " acne brown face beautifying medicinal cover and preparation method thereof "; Application number 95113989 disclosed " natural Chinese medicine face-beautifying extract "; Application number 96116066 disclosed " natural freckle-diminishing beauty treatment and preparation method thereof ".The shortcoming that these disclosed plaque dispelling skin care products exist is concluded 2 points: the one, and choosing of each component is unsatisfactory; The 2nd, the cooperative effect after each component cooperates is relatively poor, and curative effect is not obvious, does not consolidate.In addition, some speckle dispelling products on the market have added materials such as the lead of violating a ban, hydrargyrum in prescription, or intensive short cortex cracking-off agent, have damaged the normal physiological metabolism of skin, not only can not reach the speckle dispelling purpose, even cause serious consequence.Therefore, research and develop a kind of new, curative effect and significantly and to skin have the skin-whitening agents of certain health-care effect, be of great practical significance.
The object of the present invention is to provide a kind of component to select rationally can produce good synergism after each component is composite, have lightening compositions significant skin-whitening effect, safety and stability, and the application in cosmetics and external preparation for skin medicament.
Design of the present invention is such:
The reason that causes local skin pigment anomaly calmness mainly is divided into the h and E factor from many-side.Inherited genetic factors thoroughly discloses as yet, and environmental factors mainly is meant the irradiation of ultraviolet light and people's self health, as gestation, endocrine disturbance, take some drugs, hepatic disease etc.The somebody thinks certain relation that has of little disruption of ecological balance of skin and chloasma.The inventor has taken all factors into consideration the melanic various factors of formation, has proposed a kind of compositions to the effect of skin Pear Power, and said composition is made of following component:
(1) endothelin antagonist
Studies show that melanin (melanins) is produced by melanocyte (melanocyte), sophisticated melanocyte is positioned at the basal layer of epidermis cell, is a kind of dentritic cell.Each melanocyte connects about 36 epithelial cellses, constitutes an epidermal melanin unit.Epithelial cells has important regulation to melanocyte.Mainly be the melanocytic quantity of influence, dendron formation etc., wherein undifferentiated epithelial cells is stronger than the effect of differentiation.Epithelial cells is realized melanocytic regulating and controlling effect by synthetic and the secretion various kinds of cell factor.The excretory bFGF of epithelial cells plays an important role to melanocytic growth and survival.In addition, there is endothelin-1 (endothelin-1) genetic transcription in vegetative state down or in the epithelial cells of ultraviolet (UVB) irradiation, confirmed in the melanocyte system of In vitro culture that endothelin-1 can induce melanocyte to enter the S phase, strengthened melanocytic propagation.Therefore, the present invention adds a kind of endothelin antagonist in lightening compositions, can cut off the facilitation that Endothelin generates melanin under the ultraviolet effect;
(2) tyrosinase inhibitor
It is relevant with tryrosinase to generate melanic another factor, and tryrosinase generates in this biochemical reaction at melanin and plays crucial effects.At first, tyrosine is converted into DOPA (DOPA) under the catalytic action of tryrosinase, DOPA further is oxidized to DOPA quinone (DOPAaquinone), and the DOPA quinone is very fast to become dopachrome through molecule inner ring condensation, and dopachrome carries out intramolecular rearrangement, form DHI and two intermediate of DHICA, form 5 respectively at last, 6-istain and 5, the acid of 6-DHI, the two has formed excellent melanocyte (Eu-Melanins) jointly, has another name called eumelanin.Therefore as long as the activity of restraint of tyrosinase reduces the conversion of tyrosine to the DOPA quinone, just can alleviate the pigmentation of skin.The present invention adds tyrosinase inhibitor in lightening compositions, to block melanic formation;
(3) sunscreen
Ultraviolet can stimulate the melanocyte division as a kind of extrinsic factor, makes the melanocyte propagation of irradiated site.This just summer mottle than the obvious main cause that deepens or increase in winter.Studies show that UV may be by increasing melanocytic MSH (melanotropin) receptor active to melanogenic influence, thereby increase the reactivity of melanocyte MSH.After the UV irradiation, the MSH level in the blood increases, and stimulates melanocytic mitosis and transports to epithelial cells.The present invention adds certain sunscreen in lightening compositions, the stimulation that can effectively stop ultraviolet that melanin is formed;
(4) antioxidant
Add certain antioxidant in the lightening compositions, have the facilitation that suppresses the formation of radical pair melanocyte and keep the active dual-use function of tyrosinase inhibitor;
(5) cutin cracking-off agent
The forming process of melanosome was divided into for five phases: the first phase, tryrosinase is synthetic in the endoplasmic reticulum of endochylema, and the Golgi body cavity increases synthetic protein simultaneously.The second phase claims the preceding melanin granule phase.The third phase claims the melanin granule period of maturation, and melanocyte is mainly synthetic at this first phase.The fourth phase, sophisticated melanin granule is deposited in the endochylema, transports to epithelial cells by the dendritic processes of cell.The fifth phase, the release of melanin granule.The melanin granule of transferring to epithelial cells is along with epidermis cell goes upward to horny layer, and comes off and drain with horny layer.Therefore, add the cutin cracking-off agent in the lightening compositions, can promote the metabolism of epithelial cells, quicken disappearing of mottle;
(6) antiinflammatory
Because skin is when ultraviolet radiation is impaired, often follow inflammatory reaction, some inflammatory mediator that discharges in the inflammatory process such as prostaglandin, leukotriene, arachidonic acid etc. are understood by approach such as receptor that increases MSH and activated adenyl cyclases, make melanocyte propagation, melanosome is synthetic to be increased, and causes pigmentation.Therefore, add antiinflammatory, can eliminate the facilitation that various inflammatory factors form melanocyte.
The said lightening compositions of the present invention, its component and content are:
Tyrosinase inhibitor 0.10～15.0
Sunscreen 0.50～15.0
Endothelin antagonist 0.01～8.0
Antiinflammatory 0.10～8.0
Cutin cracking-off agent 0.10～10.0
Antioxidant 0.10～10.0
Water surplus
Below all be weight percentage (down together).
The preferred ratio of each component is:
Tyrosinase inhibitor 0.5～12.0
Sunscreen 0.5～12.0
Endothelin antagonist 0.01～5.0
Antiinflammatory 0.1～6.0
Cutin cracking-off agent 0.5～8.0
Antioxidant 0.1～8.0
Water surplus
The more preferred ratio of each component is:
Tyrosinase inhibitor 1.0～10.0
Sunscreen 1.0～8.0
Endothelin antagonist 0.05～2.0
Antiinflammatory 0.5～4.0
Cutin cracking-off agent 1.0～5.0
Antioxidant 0.5～6.0
Water surplus
Said tyrosinase inhibitor comprises one or more in commercially available kojic acid, arbutin, Cortex Mori extract, the Radix Angelicae Sinensis extract etc.;
Said sunscreen comprises physical sunscreen agent and chemical sunscreen;
The physical sunscreen agent mainly comprises superfine titanium white, super fine zinc oxide etc.;
The chemistry sunscreen mainly comprises one or more in para-amino benzoic acid and derivant thereof, salicylate (salt) analog derivative, cinnamate analog derivative, benzophenone, the o-aminobenzoa etc.;
Said endothelin antagonist is the endothelin antagonist that Shanghai Ao Li Industrial Co., Ltd produces.
Said antiinflammatory comprises one or more in commercially available arnica montana extract, chamomile extract, Fructus Crataegi extract, Citrus aurantium Linn. flower extract, Salvia japonica Thunb., farnesol, α-bisabolol, Aloe, the allantoin etc.;
Said cutin cracking-off agent comprises one or more in malic acid, Fructus Citri Limoniae juice extract, Alpha-hydroxy acetic acid and the derivant thereof etc.;
Said antioxidant comprises one or more in vitamin E and derivant, vitamin C and derivant thereof, green tea extract, toluene di-tert-butyl phenol etc.;
Above-mentioned various plant extract, can adopt conventional method to be prepared as Cortex Mori extract, Radix Angelicae Sinensis extract, green tea extract, arnica montana extract, chamomile extract, Fructus Crataegi extract and Citrus aurantium Linn. flower extract etc., the content of its active component is generally 5%～30%, (percentage by weight).
Said lightening compositions also is preparation like this:
After each component accurately weighed in proportion, mix homogeneously got final product.
Said lightening compositions can be used for as facial film, skin whitener and whitening emulsion etc., also can be used as whitening additive in the various cosmetics, is used for general external preparation for skin medicament, and addition is generally 1%-20% (weight).
Below will the invention will be further elaborated by embodiment, but embodiment does not limit protection scope of the present invention.
Embodiment 1
Arbutin 4 grams, superfine titanium white 3.2 grams, endothelin antagonist 0.8 gram (deriving from Shanghai Ao Li Industrial Co., Ltd), allantoin 1.6 grams, fruit acid 2.0 grams, green tea extract 2.4 grams and deionized water 86 grams are placed blender, mix, can obtain said skin lightening compositions.
Tyrosinase inhibition test:
Generate in the melanic process in tyrosine reaction, the catalytic action of tryrosinase occurs in mainly that tyrosine is converted into the L-DOPA and the L-DOPA is converted in these two reactions of DOPA quinone.The DOPA quinone is a coloring matter, can observe and measure with ultraviolet spectrometer (475nm).
Fig. 1 is the different active comparison of whitening agent restraint of tyrosinase.
Cell experiment:
Tested material is added in the B16 mouse melanin tumor cell of in vitro culture, cultivates 48h, Observe the impact of tested material cell growth, collect respectively again the cell on each culture plate, advance Row is centrifugal, observes the light color degree (seeing Table 1) of harvesting.
Tested material title viable count is (individual/ml) harvesting light color degree
Blank 5.9 * 1050 lightening compositions (embodiment 1) 5.6 * 105 ++++
Pfansteihl 0 +++
Arbutin No. 10 ++
Arbutin No. 20 ++
Table 1 whitening agent is annotated the influence of B16 cell growth: ++ ++ expression cell light color degree is the highest ++ and+expression cell light color degree is higher ++ and expression cell light color degree is general
The result shows that the said lightening compositions pair cell of the present invention light color degree is the highest, and it is the strongest to suppress the ability that B16 cell melanin generates, L-lactic acid secondly, No. 1, arbutin and No. 2 are then minimum, the ability that suppresses the generation of B16 cell melanin is the poorest.And lightening compositions of the present invention has no side effect to human body.
Embodiment 2
The preparation of cleawhite pack:
Earlier 8 kilograms of polyvinyl alcohol and 67.05 kilograms of deionized waters are added agitated kettle, be heated to 80-85 ℃, stirring and dissolving is again with 15 kilograms of ethanol, 934, the 1 kilogram of polyoxyethylene hydrogenated Oleum Ricini in 0.35 kilogram calorie POP, 0.35 kilogram triethanolamine and 8 kilograms of above-mentioned lightening compositions add agitated kettle, be heated with stirring to 70 ℃, after the dissolving evenly, be cooled to 55 ℃, add 0.2 kilogram of essence and 0.05 kilogram of isothiazolone, when being cooled to 40 ℃, stop to stir discharging.
Embodiment 3
The preparation of skin whitener:
Successively with 1.5 kilograms of polyoxyethylene aliphatic alcohol ethers, 2 kilograms of glyceryl monostearates, 10 kilograms of glycerol, 10 kilograms of white oils, 5 kilograms of isopropyl palmitates, 5 kilogram 16-18 mixed alcohol and 1 kilogram of dimethicone add the oil phase pot, be heated to 80-85 ℃, stir, in addition with 0.1 kilogram of methyl hydroxybenzoate, 14 kilograms of above-mentioned lightening compositions, 51.05 the kilogram deionized water adds the water pot, be heated to 80-85 ℃, earlier water is added reaction pot, homogenizing stirs, add oil phase again, homogenizing is after 5 minutes, about cooling and stirring to 55 ℃, add 0.3 kilogram of essence and 0.05 kilogram of isothiazolone, be cooled to 40 ℃, stop to stir discharging.
Embodiment 4
The preparation of whitening emulsion:
Successively with 1.4 kilograms of polyoxyethylene aliphatic alcohol ethers, 1.8 kilogram glyceryl monostearate, 8 kilograms of glycerol, 8 kilograms of white oils, 5 kilograms of isopropyl palmitates, 5 kilograms of sorbitol, 1 kilogram 16-18 mixed alcohol and 0.5 kilogram of dimethicone add the oil phase pot, be heated to 80-85 ℃, stir, in addition with 0.1 kilogram of methyl hydroxybenzoate, 10 kilograms of above-mentioned lightening compositions, 0.25 kilogram calorie POP 934,0.25 kilogram triethanolamine, 58.45 the kilogram deionized water adds the water pot, be heated to 80-85 ℃, earlier water is added reaction pot, homogenizing stirs, add oil phase again, behind the homogenizing 5 minutes, about cooling and stirring to 55 ℃, add 0.2 kilogram of essence and 0.05 kilogram of isothiazolone, be cooled to 40 ℃, stop to stir discharging.
According to the whitening emulsion and the skin whitener of above-mentioned Formula Design thinking preparation, cooperate cleawhite pack to carry out the usefulness experiment, and use color difference meter its effect is assessed observation clinical.
The volunteer is 50 middle-aged womens about 40 years old, and position on probation is a face; After clean, be applied to the test position for twice on the one.Observing with testing the position is two cheekbone portions, and right forearm inboard is untreated contrast position.At the beginning of experiment starts from midsummer (zero-time on June 15th, 98), measure each position respective value with color difference meter before the experiment beginning, test in after this every month once.The result shows after using in three months, have significantly before its L-value (lightness) uses and increase (P＜0.05).The inboard arm at position its L-value in whole midsummer process has obvious decline in contrast.This result shows that this whitening product can not only increase facial lightness, and can resist the blackening effect of ultraviolet to skin.
Claims (10)
1. skin lightening compositions is characterized in that component and content are:
Tyrosinase inhibitor 0.10～15.0
Sunscreen 0.50～15.0
Endothelin antagonist 0.01～8.0
Antiinflammatory 0.10～8.0
Cutin cracking-off agent 0.10～10.0
Antioxidant 0.10～10.0
Water surplus
Below all be weight percentage;
2. compositions as claimed in claim 1 is characterized in that component and content are:
Tyrosinase inhibitor 0.5～12.0
Sunscreen 0.5～12.0
Endothelin antagonist 0.01～5.0
Antiinflammatory 0.1～6.0
Cutin cracking-off agent 0.5～8.0
Antioxidant 0.1～8.0
Water surplus
Below all be weight percentage.
3. compositions as claimed in claim 2 is characterized in that component and content are:
Tyrosinase inhibitor 1.0～10.0
Sunscreen 1.0～8.0
Endothelin antagonist 0.05～2.0
Antiinflammatory 0.5～4.0
Cutin cracking-off agent 1.0～5.0
Antioxidant 0.5～6.0
Water surplus
Below all be weight percentage.
4. compositions as claimed in claim 1 is characterized in that:
Said tyrosinase inhibitor comprises one or more in commercially available kojic acid, arbutin, Cortex Mori extract or the Radix Angelicae Sinensis extract;
Said sunscreen comprises one or more in superfine titanium white, super fine zinc oxide, para-amino benzoic acid and derivant thereof, salicylate (salt) analog derivative, cinnamate analog derivative, benzophenone or the o-aminobenzoa;
Said endothelin antagonist is the endothelin antagonist that Shanghai Ao Li Industrial Co., Ltd produces;
Said antiinflammatory comprises one or more in commercially available arnica montana extract, chamomile extract, Fructus Crataegi extract, Citrus aurantium Linn. flower extract, Salvia japonica Thunb., farnesol, α-bisabolol, Aloe or the allantoin;
Said cutin cracking-off agent comprises one or more in malic acid, Fructus Citri Limoniae juice extract, Alpha-hydroxy acetic acid and the derivant thereof;
Said antioxidant comprises one or more in vitamin E and derivant, vitamin C and derivant thereof, green tea extract or the toluene di-tert-butyl phenol.
5. compositions as claimed in claim 2 is characterized in that:
Said tyrosinase inhibitor comprises one or more in commercially available kojic acid, arbutin, Cortex Mori extract or the Radix Angelicae Sinensis extract;
Said sunscreen comprises one or more in superfine titanium white, super fine zinc oxide, para-amino benzoic acid and derivant thereof, salicylate (salt) analog derivative, cinnamate analog derivative, benzophenone or the o-aminobenzoa;
Said endothelin antagonist is the endothelin antagonist that Shanghai Ao Li Industrial Co., Ltd produces;
Said antiinflammatory comprises one or more in commercially available arnica montana extract, chamomile extract, Fructus Crataegi extract, Citrus aurantium Linn. flower extract, Salvia japonica Thunb., farnesol, α-bisabolol, Aloe or the allantoin;
Said cutin cracking-off agent comprises one or more in malic acid, Fructus Citri Limoniae juice extract, Alpha-hydroxy acetic acid and the derivant thereof;
Said antioxidant comprises one or more in vitamin E and derivant, vitamin C and derivant thereof, green tea extract or the toluene di-tert-butyl phenol.
6. compositions as claimed in claim 2 is characterized in that:
Said tyrosinase inhibitor comprises one or more in commercially available kojic acid, arbutin, Cortex Mori extract or the Radix Angelicae Sinensis extract;
Said sunscreen comprises one or more in superfine titanium white, super fine zinc oxide, para-amino benzoic acid and derivant thereof, salicylate (salt) analog derivative, cinnamate analog derivative, benzophenone or the o-aminobenzoa;
Said endothelin antagonist is the endothelin antagonist that Shanghai Ao Li Industrial Co., Ltd produces;
Said antiinflammatory comprises one or more in commercially available arnica montana extract, chamomile extract, Fructus Crataegi extract, Citrus aurantium Linn. flower extract, Salvia japonica Thunb., farnesol, α-bisabolol, Aloe or the allantoin;
Said cutin cracking-off agent comprises one or more in malic acid, Fructus Citri Limoniae juice extract, Alpha-hydroxy acetic acid and the derivant thereof;
Said antioxidant comprises one or more in vitamin E and derivant, vitamin C and derivant thereof, green tea extract or the toluene di-tert-butyl phenol.
7. the application of compositions as claimed in claim 1 is characterized in that can be used for cosmetics.
8. the application of compositions as claimed in claim 2 is characterized in that can be used for cosmetics.
9. the application of compositions as claimed in claim 3 is characterized in that can be used for cosmetics.
10. as claim 1, or 2, or the application of 3 described compositionss, it is characterized in that can be used as additive and be used for the external preparation for skin medicament.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99124005A CN1100526C (en) | 1999-11-12 | 1999-11-12 | Skin beautifying and whitening composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99124005A CN1100526C (en) | 1999-11-12 | 1999-11-12 | Skin beautifying and whitening composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1255329A true CN1255329A (en) | 2000-06-07 |
| CN1100526C CN1100526C (en) | 2003-02-05 |
Family
ID=5283103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99124005A Expired - Lifetime CN1100526C (en) | 1999-11-12 | 1999-11-12 | Skin beautifying and whitening composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1100526C (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1222913A4 (en) * | 1999-10-21 | 2003-06-25 | Kao Corp | Depilatories and agents for external use |
| CN104127330A (en) * | 2014-07-17 | 2014-11-05 | 禄美生物科技（上海）有限公司 | Spot-removing essence emulsion and preparation method thereof |
| CN104257566A (en) * | 2014-10-22 | 2015-01-07 | 天津郁美净集团有限公司 | Composition for cosmetics with conditioning action as well as application thereof |
| CN104780898A (en) * | 2012-11-15 | 2015-07-15 | 株式会社资生堂 | Melanin production inhibitor |
| CN104886241A (en) * | 2015-05-08 | 2015-09-09 | 江南大学 | A browning inhibitor for fresh-cut fruits and vegetables and a preparation method thereof |
| CN107595670A (en) * | 2017-08-17 | 2018-01-19 | 黄敏 | Whitening and smoothing toner |
| CN107823002A (en) * | 2017-12-08 | 2018-03-23 | 佛山实瑞先导材料研究院（普通合伙） | A kind of antitan agent composition |
| CN107823098A (en) * | 2017-12-08 | 2018-03-23 | 佛山实瑞先导材料研究院（普通合伙） | A kind of resisting skin allergy composition |
| WO2018152758A1 (en) * | 2017-02-24 | 2018-08-30 | 拉芳家化股份有限公司 | Anti-inflammatory emulsion |
-
1999
- 1999-11-12 CN CN99124005A patent/CN1100526C/en not_active Expired - Lifetime
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1222913A4 (en) * | 1999-10-21 | 2003-06-25 | Kao Corp | Depilatories and agents for external use |
| US7468421B2 (en) | 1999-10-21 | 2008-12-23 | Kao Corporation | Depilatories and agents for external use |
| CN104780898B (en) * | 2012-11-15 | 2017-04-05 | 株式会社资生堂 | Melanogenesis inhibitor |
| CN104780898A (en) * | 2012-11-15 | 2015-07-15 | 株式会社资生堂 | Melanin production inhibitor |
| KR20150082191A (en) * | 2012-11-15 | 2015-07-15 | 가부시키가이샤 시세이도 | Melanin production inhibitor |
| KR102104150B1 (en) | 2012-11-15 | 2020-04-23 | 가부시키가이샤 시세이도 | Melanin production inhibitor |
| CN104127330A (en) * | 2014-07-17 | 2014-11-05 | 禄美生物科技（上海）有限公司 | Spot-removing essence emulsion and preparation method thereof |
| CN104257566A (en) * | 2014-10-22 | 2015-01-07 | 天津郁美净集团有限公司 | Composition for cosmetics with conditioning action as well as application thereof |
| CN104257566B (en) * | 2014-10-22 | 2017-02-01 | 天津郁美净集团有限公司 | Composition for cosmetics with conditioning action as well as application thereof |
| CN104886241B (en) * | 2015-05-08 | 2018-06-08 | 江南大学 | A kind of fresh-cut fruit and vegetable browning inhibitor and preparation method thereof |
| CN104886241A (en) * | 2015-05-08 | 2015-09-09 | 江南大学 | A browning inhibitor for fresh-cut fruits and vegetables and a preparation method thereof |
| WO2018152758A1 (en) * | 2017-02-24 | 2018-08-30 | 拉芳家化股份有限公司 | Anti-inflammatory emulsion |
| CN109121393A (en) * | 2017-02-24 | 2019-01-01 | 拉芳家化股份有限公司 | A kind of anti-inflammatory lotion |
| CN107595670A (en) * | 2017-08-17 | 2018-01-19 | 黄敏 | Whitening and smoothing toner |
| CN107823002A (en) * | 2017-12-08 | 2018-03-23 | 佛山实瑞先导材料研究院（普通合伙） | A kind of antitan agent composition |
| CN107823098A (en) * | 2017-12-08 | 2018-03-23 | 佛山实瑞先导材料研究院（普通合伙） | A kind of resisting skin allergy composition |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1100526C (en) | 2003-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8435547B2 (en) | Cream for stimulating mitochondrial activity in the skin | |
| CN1157181C (en) | Use of conjugated linoleic acid (CLA) for topical treatment of cellulite | |
| CN111202695A (en) | Natural edible composition with health care function, application thereof, makeup cosmetic and preparation method thereof | |
| CN102198066B (en) | New whitening and freckle eliminating agent for use in cosmetics | |
| CN101032459B (en) | Emulsion including coenzyme Q10 and vegetal essence and preparing method thereof | |
| FR2984742A1 (en) | USE OF STEVIOL, A GLYCOSIDE DERIVATIVE OF STEVIOL, OR ANY OF THEIR ISOMERS, FOR PREVENTING, REDUCING AND / OR TREATING AN ALTERATION OF SKIN PAINT. | |
| CN108524357A (en) | A kind of fresh and alive beautiful fine flour frost of the root extract containing Aplotaxis auriculata and preparation method thereof | |
| CN111743796A (en) | Whitening milk and preparation method thereof | |
| CN114588068A (en) | Composition with skin whitening and spot lightening effects | |
| CN1100526C (en) | Skin beautifying and whitening composition | |
| JP2020511514A (en) | Composition for promoting melanin production containing thistle extract as an active ingredient | |
| EP0970693B1 (en) | Biologically active labdane or labdene derivatives from Cistus | |
| WO2024109386A1 (en) | Skin whitening composition capable of promoting permeation and enhancing effects | |
| JP2001158728A (en) | Agent for promoting production of hyaluronic acid and skin preparation for external use | |
| CN1507852A (en) | Use of ascorbic-acid dervative as bleaching agent for beauty | |
| KR101247153B1 (en) | A Cosmetic composition containing Acerola extract powder coated with silicone oil mixture | |
| CN114869817B (en) | Composition with whitening effect and preparation method thereof | |
| CN101703461A (en) | Skin-whitening speckle-removing cream and preparation method thereof | |
| CN1059562C (en) | Natural vigour beauty and skin-protecting cream and its preparing method | |
| CN101822624A (en) | Composition containing thioctic acid and extract of root of red-rooted salvia and application thereof in cosmetics | |
| KR20020008268A (en) | Testosterone 5 alpha-reductase inhibitors containing extracts of galla rhois | |
| CN106031708A (en) | Pharmaceutical composition with effects of skin care, wrinkle removing, and anti-aging effect, and preparation method thereof | |
| CN108403588A (en) | Natural animal-plant skin cream | |
| CN108653144A (en) | A kind of skin-lightening cosmetic | |
| KR20100083203A (en) | Method for producing skin whitening products using the king oyster mushroom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20030205 |
|
| CX01 | Expiry of patent term |